Document Detail

Prescribing trends with daptomycin (cubicin) for the treatment of gram-positive infections.
MedLine Citation:
PMID:  19561791     Owner:  NLM     Status:  In-Data-Review    
The injectable agent daptomycin, when prescribed according to approved guidelines, can be a welcome option for treating some multiresistant, gram-positive infections that have become increasingly prevalent.
Noreen H Chan Tompkins; Stephen J Harnicar
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  P & T : a peer-reviewed journal for formulary management     Volume:  33     ISSN:  1052-1372     ISO Abbreviation:  P T     Publication Date:  2008 May 
Date Detail:
Created Date:  2009-06-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9015516     Medline TA:  P T     Country:  United States    
Other Details:
Languages:  eng     Pagination:  282-8     Citation Subset:  -    
Dr. Tompkins is a Clinical Specialist in Infectious Diseases at Allegheny General Hospital's Department of Pharmacy in Pittsburgh, Pennsylvania. At the time of this project, Dr. Harnicar was a Pharmacy Technician at Allegheny General Hospital. He is currently an Oncology Pharmacy Resident at Memorial Sloan-Kettering Cancer Center in New York, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mesangioproliferative glomerulonephritis in an infant with Prader-Willi syndrome.
Next Document:  Effect of Persistence with Drug Therapy On the Risk of Myocardial Re-infarction.